EX-99.1 2 ef20086010_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1


Magnera Reports Fourth Quarter and Fiscal Year Results

Fourth Quarter Highlights
•
GAAP: Net sales of $851 million; Operating loss of $90 million (includes $106 million of goodwill and other impairment)
•
Non-GAAP: Adjusted EBITDA of $97 million
•
Record cash flow with cash from operations of $99 million
•
$57 million of debt repayments

Fiscal Year Highlights
•
GAAP: Net sales of $3.3 billion; Operating loss of $37 million (includes $106 million of goodwill and other impairment)
•
Non-GAAP: Adjusted EBITDA of $378 million
•
Free cash flow of $115 million represents a yield of over 25% as of year-end
•
$122 million of debt repayments

 
Curt Begle, Magnera’s CEO, commented: “We finished Fiscal 2026 with an impressive 8% Adjusted EBITDA improvement in the fourth quarter compared to last year and delivered strong overall results for the full year surpassing prior year by nearly 4%. Through the successful implementation of Project CORE, ongoing realization of synergies, and a relentless focus on operational excellence, we are optimizing our cost structure, enhancing profitability, and generating exceptional cash flow. Our teams delivered these results while navigating inflationary pressures and dynamic demand conditions across our end markets, demonstrating the resilience and flexibility of our operating model.

As we enter fiscal 2027, we remain focused on driving profitable growth and advancing our productivity and cost initiatives. While we remain mindful of the broader macroeconomic environment, we are confident that the strength of our team, our market positions, and our disciplined execution will continue to support sustainable earnings growth and strong cash generation.”
 

Key Financials

 
September Quarter
Fiscal Year
GAAP results
2026
2025
2026
2025
Net sales
$ 851
$ 839
$ 3,296
$ 3,204
Operating income (loss)
  (90)
     10
    (37)
 5

 
September Quarter
Reported
Comparable(1)
Fiscal Year
Reported
Comparable(1)
Adjusted non-GAAP results
2026
2025
%
%
2026
2025
%
%
Net sales
$851
$839
1%
1%
$3,296
$3,204
3%
(4%)
Adjusted EBITDA (1)
   97
   90
8%
8%
     378
     354
7%
4%

(1)
Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change % normalizes the impacts of foreign currency and the recent M&A activity. Further details related to non-GAAP measures and reconciliations can be found under “Reconciliation of Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release. Dollars in millions

Page | 1

Financial Results – Fourth Quarter 2026

Consolidated Overview

The net sales increase included a $43 million increase in selling prices primarily due to the pass-through of higher raw material costs partially offset by a 4% organic volume decline. The volume decline was primarily attributed to softer healthcare demand in Americas and continued general market softness in Europe.

The Adjusted EBITDA was up 8% primarily as a result of favorable price cost spread of $9 million.

Americas

The net sales increase included a $19 million increase in selling prices primarily due to the pass-through of higher raw material costs partially offset by a 2% organic volume decline.

The Adjusted EBITDA improvement was primarily a result of favorable price cost spread of $4 million due to the realized benefits from project CORE and merger synergies.

Rest of World

The net sales were essentially flat as a $24 million increase in selling prices due to the pass-through of higher raw material costs was offset by a 6% organic volume decline.

The adjusted EBITDA improvement was primarily a result of favorable price cost spread of $5 million due to the realized benefits from project CORE and synergies partly offset by the negative impact from lower volumes.

Free Cash Flow and Net Debt - Fiscal Year 2026

Magnera is committed to strengthening its credit metrics by paying down debt in the near term.

(in millions)
Fiscal Year
Cash flow from operating activities
$ 178
Additions to property, plant and equipment, net
   (63)
Free cash flow (1)
$ 115
Free cash flow yield (1)
> 25%
(1)FCF yield as of 9/26 close of business market cap. Further details related to non-GAAP measures and reconciliations can be found under “Reconciliation of Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.

Fiscal Year 2027 Guidance

•
Adjusted EBITDA of $390 - $410 million
•
Free cash flow of $110 - $130 million; cash flow from operations of $195 - $215 million

Investor Conference Call

The Company will host a conference call tomorrow, November 19, 2026, at 10:00 AM U.S. Eastern Time to discuss the Fourth Quarter and Fiscal Year 2026 results. The webcast can be accessed here. A replay of the webcast will be available via the same link on the Company’s website after the completion of the call.

By Telephone
Participants may register for the call here now or any time up to and during the time of the call and will immediately receive the dial-in number and a unique pin to access the call. While you may register at any time up to and during the time of the call, you are encouraged to join the call 15 minutes prior to the start of the event.

Page | 2

About Magnera

Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 44 global facilities, Magnera is supported by over 8,000+ employees. Magnera’s purpose is to better the world with new possibilities made real. For more than 160 years, the Company has delivered the material solutions their partners need to thrive. Through economic upheaval, global pandemics and changing end-user needs, we have consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of products brings customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.

Visit Magnera.com for more information and follow @MagneraCorporation on social platforms.

Non-GAAP Financial Measures and Estimates
This press release includes non-GAAP financial measures including, but not limited to, Adjusted EBITDA, free cash flow, and comparable basis net sales and adjusted EBITDA. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in the United States of America (GAAP) is set forth at the end of this press release. Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow are not provided because such information is not available without unreasonable effort due to high variability, complexity, and low visibility with respect to certain items, including debt refinancing activity or other non-comparable items. These items are uncertain, depend on various factors, and could be material to our results computed in accordance with U.S. GAAP.

Forward Looking Statements
This document contains certain statements that are “forward-looking” statements within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such “forward-looking” statements include, but are not limited to, statements with respect to our future financial performance and condition, results of operations and business, our expectations or beliefs concerning future events, plans, objectives, expectations and intentions, and other statements that are not historical facts. These statements may contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “outlook,” “guidance,” “anticipates” or “looking forward” or similar expressions. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Although it is not possible to identify all of these risks and uncertainties, they include, among others, the following: global economic conditions; inflation; the cost and availability of raw materials and energy; disruption of our supply chain; the adverse impact of weather events on our facilities, inventory and suppliers, as well as adverse effects on our customers, suppliers and other business partners; the effect of competition on our business; our inability to integrate future acquired companies or to realize expected operating synergies; synergies expected to be achieved in connection with our business combination with a subsidiary of Berry Global Group, Inc.; our inability to retain our officers and employees or the occurrence of labor disputes; disruption of our information technology systems, including as a result of a cyber breach; risks associated with operating internationally, including fluctuating exchange rates, tariffs, differing tax laws and regulation; litigation and regulatory investigations; and disputes related to intellectual property used in our business. Additional information regarding these risks and uncertainties and other risks applicable to our business are described in additional detail in our reports filed with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the fiscal year ended September 26, 2026, and other filings that we make with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time, and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Page | 3

Consolidated and Combined Statements of Operations (unaudited)

   
Quarterly Period Ended
   
Fiscal Year Ended
 
(in millions of dollars)
 
September 26, 2026
   
September 27, 2025
   
September 26, 2026
   
September 27, 2025
 
                         
Net sales
 
$
851
   
$
839
   
$
3,296
   
$
3,204
 
                                 
Cost of goods sold
   
750
     
751
     
2,891
     
2,867
 
Selling, general and administrative
   
47
     
49
     
203
     
193
 
Amortization of intangibles
   
12
     
9
     
46
     
50
 
Restructuring and other
   
26
     
20
     
87
     
89
 
Goodwill and other impairment
   
106
     
-
     
106
     
-
 
Operating income (loss)
   
(90
)
   
10
     
(37
)
   
5
 
Other expense (income)
   
(21
)
   
4
     
(16
)
   
30
 
Interest net expense
   
38
     
39
     
150
     
141
 
Income (loss) before income taxes
   
(107
)
   
(33
)
   
(171
)
   
(166
)
Income tax (benefit) expense
   
34
     
7
     
42
     
(7
)
Net income (loss)
 
$
(141
)
 
$
(40
)
 
$
(213
)
 
$
(159
)

Condensed Consolidated and Combined Statements of Cash Flows (unaudited)

   
Fiscal Year
 
(in millions of dollars)
 
2026
   
2025
 
Net cash from operating activities
   
178
     
103
 
                 
Cash flows from investing activities:
               
Additions to property, plant, and equipment, net
   
(63
)
   
(67
)
Cash acquired from GLT acquisition
   
-
     
37
 
Other investing activities
   
(3
)
   
22
 
Net cash from (used in) investing activities
   
(66
)
   
(8
)
                 
Cash flows from financing activities:
               
Proceeds from long-term borrowings
   
-
     
1,556
 
Repayments on long-term borrowings
   
(122
)
   
(484
)
Transfers from (to) Berry, net
   
-
     
34
 
Cash distribution to Berry
   
-
     
(1,111
)
Debt fees and other, net
   
(1
)
   
(16
)
Net cash from (used in) financing activities
   
(123
)
   
(21
)
Effect of currency translation on cash
   
-
     
1
 
Net change in cash and cash equivalents
   
(11
)
   
75
 
Cash and cash equivalents at beginning of period
   
305
     
230
 
Cash and cash equivalents at end of period
 
$
294
   
$
305
 

Condensed Consolidated Balance Sheets (unaudited)

(in millions of dollars)
 
September 26, 2026
   
September 27, 2025
 
Cash and cash equivalents
 
$
294
   
$
305
 
Accounts receivable
   
502
     
522
 
Inventories
   
499
     
474
 
Other current assets
   
67
     
122
 
Property, plant, and equipment
   
1,366
     
1,476
 
Goodwill, intangible assets, and other long-term assets
   
893
     
1,090
 
Total assets
 
$
3,621
   
$
3,989
 
Current liabilities, excluding current debt
   
615
     
601
 
Current and long-term debt
   
1,848
     
1,952
 
Other long-term liabilities
   
272
     
371
 
Stockholders’ equity
   
886
     
1,064
 
Total liabilities and stockholders' equity
 
$
3,621
   
$
3,989
 

Page | 4

Reconciliation of Non-GAAP Measures
(in millions of dollars)

Reconciliation of Net sales and Adjusted EBITDA on a supplemental comparable basis by segment
 
   
   
Quarterly Period ended September 26, 2026
   
Quarterly Period ended September 27, 2025
 
   
Americas
   
Rest of World
   
Total
   
Americas
   
Rest of World
   
Total
 
Net sales
 
$
483
   
$
368
   
$
851
   
$
467
   
$
372
   
$
839
 
Constant FX rates
                           
6
     
(2
)
   
4
 
PF divestiture
                           
-
     
(4
)
   
(4
)
Comparable net sales (1)(6)
 
$
483
   
$
368
   
$
851
   
$
473
   
$
366
   
$
839
 
                                                 
Operating income (loss)
 
$
(39
)
 
$
(51
)
 
$
(90
)
 
$
11
   
$
(1
)
 
$
10
 
Depreciation and amortization
   
27
     
23
     
50
     
25
     
12
     
37
 
Transaction, business consolidation and other activities (2)
   
8
     
12
     
20
     
15
     
15
     
30
 
Argentina hyperinflation
   
1
     
-
     
1
     
3
     
-
     
3
 
Goodwill and other impairment
   
65
     
41
     
106
     
-
     
-
     
-
 
GAAP carve-out allocation (3)
   
-
     
-
     
-
     
-
     
-
     
-
 
Other non-cash charges (4) (5)
   
3
     
7
     
10
     
6
     
4
     
10
 
Adjusted EBITDA (1)
 
$
65
   
$
32
   
$
97
   
$
60
   
$
30
   
$
90
 
Constant FX rates
                           
1
     
(1
)
   
-
 
PF divestiture
                           
-
     
-
     
-
 
Comparable Adjusted EBITDA (1)(6)
 
$
65
   
$
32
   
$
97
   
$
61
   
$
29
   
$
90
 
% vs. prior year comparable
   
7
%
   
10
%
   
8
%
                       

   
2026 Fiscal Year Ended
   
2025 Fiscal Year Ended
 
   
Americas
   
Rest of World
   
Total
   
Americas
   
Rest of World
   
Total
 
Net sales
 
$
1,835
   
$
1,461
   
$
3,296
   
$
1,833
   
$
1,371
   
$
3,204
 
Constant FX rates
                           
35
     
74
     
109
 
PF divestiture and merger
                           
42
     
66
     
108
 
Comparable net sales (1)(6)
 
$
1,835
   
$
1,461
   
$
3,296
   
$
1,910
   
$
1,511
   
$
3,421
 
                                                 
Operating income (loss)
 
$
3
   
$
(40
)
 
$
(37
)
 
$
24
   
$
(19
)
 
$
5
 
Depreciation and amortization
   
122
     
78
     
200
     
132
     
74
     
206
 
Transaction, business consolidation and other activities (2)
   
45
     
28
     
73
     
58
     
36
     
94
 
Argentina hyperinflation
   
4
     
-
     
4
     
4
     
-
     
4
 
Goodwill and other impairment
   
65
     
41
     
106
     
-
     
-
     
-
 
GAAP carve-out allocation (3)
   
-
     
-
     
-
     
2
     
1
     
3
 
Other non-cash charges (4)(5)
   
12
     
20
     
32
     
21
     
21
     
42
 
Adjusted EBITDA (1)
 
$
251
   
$
127
   
$
378
   
$
241
   
$
113
   
$
354
 
Constant FX rates
                           
1
     
2
     
3
 
PF divestiture and merger
                           
5
     
3
     
8
 
Comparable Adjusted EBITDA (1)(6)
 
$
251
   
$
127
   
$
378
   
$
247
   
$
118
   
$
365
 
% vs. prior year comparable
   
2
%
   
8
%
   
4
%
                       
PF divestiture and merger
                   
(2
)
                   
(2
)
Synergies and cost reductions
                   
21
                         
PF Adjusted EBITDA
                 
$
397
                         

Guidance (7)
 
Fiscal 2027
 
Adjusted EBITDA
Fiscal 2027 Midpoint
Fiscal 2026 Actual
Cash flow from operating activities
$195 - $215
 
Adjusted EBITDA
$400
$378
Additions to PPE (net)
(85)
 
% vs. prior year
~6%
 
Free Cash Flow
$110 - $130
       


1.
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Management believes that Adjusted EBITDA and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management’s view, do not reflect our core operating performance. We define “free cash flow” as cash flow from operating activities less net additions to property, plant, and equipment. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We believe free cash flow is also useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash.

We also use Adjusted EBITDA and comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA is a measure widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe these measures are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods.


2.
Includes restructuring, business optimization and other charges, which includes $19 million of transaction compensation expense in the prior year

3.
Consists of estimated parent-allocated charges for the period prior to merger which is required by GAAP as part of the carve-out financial statement process

4.
Prior year includes a $4 million and $16 million inventory step-up charge related to the merger in the quarter and YTD, respectively

5.
Includes expense for stock compensation, sale/disposal of assets, and other non-cash charges

6.
The prior year comparable basis change excludes the impacts of foreign currency and divestitures/acquisitions/mergers

7.
Assumes constant-currency basis

IR Contact Information
Robert Weilminster
EVP, Investor Relations


Page | 5